Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2006 Sep 8;241(1):1-12.
doi: 10.1016/j.canlet.2005.10.006. Epub 2005 Nov 17.

Endocrine Disrupting Compounds and Prostate Cancer

Affiliations
Review

Endocrine Disrupting Compounds and Prostate Cancer

J K Hess-Wilson et al. Cancer Lett. .

Abstract

Prostate cancer is a major health concern and is treated based on its hormone dependence. Agents that alter hormone action can have substantial biological effects on prostate cancer development and progression. As such, there is significant interest in uncovering the potential effects of endocrine disrupting compound (EDC) exposure on prostate cancer. The present review is focused on agents that alter hormone action in the prostate and how they may impact cancer growth or treatment.

Similar articles

See all similar articles

Cited by 6 articles

See all "Cited by" articles

LinkOut - more resources

Feedback